Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Ushijima

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|June 26, 2026
Better Outcomes After Initiation of Disease-Modifying Therapy in Patients with Transthyretin Cardiac AmyloidosisMakiko Nakamura, Teruhiko Imamura, Masaki Nakagaito, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 8, 2014
Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle sympathetic nerve activity in patients with heart failureRyuichi Ushijima, Shuji Joho, Takashi Akabane, et al.
Journal of Cardiac Failure|June 12, 2016
Restrictive Lung Function Is Related to Sympathetic Hyperactivity in Patients With Heart FailureShuji Joho, Ryuichi Ushijima, Takashi Akabane, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2020
A Young Patient Presenting with Atrioventricular Block Diagnosed as Myotonic DystrophyHiroshi Onoda, Teruhiko Imamura, Ryuichi Ushijima, et al.
Biomedicines|March 29, 2023
Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart FailureMasaki Nakagaito, Teruhiko Imamura, Ryuichi Ushijima, et al.
Journal of Clinical Medicine|June 19, 2024
The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart FailureMasaki Nakagaito, Teruhiko Imamura, Ryuichi Ushijima, et al.
International Heart Journal|June 1, 2022
Responders to Sodium-Glucose Cotransporter 2 Inhibitors in Improving Left Ventricular FunctionMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
Journal of Clinical Medicine|September 9, 2022
Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart FailureMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
International Heart Journal|July 19, 2021
Relationship Between HbA1c Level and Effectiveness of SGLT2 Inhibitors in Decompensated Heart Failure Patients with Type 2 Diabetes MellitusMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
International Heart Journal|July 19, 2021
Efficacy of Continuing SGLT2 Inhibitors on Outcomes in Patients with Acute Decompensated Heart FailureMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|June 26, 2026
Better Outcomes After Initiation of Disease-Modifying Therapy in Patients with Transthyretin Cardiac AmyloidosisMakiko Nakamura, Teruhiko Imamura, Masaki Nakagaito, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 8, 2014
Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle sympathetic nerve activity in patients with heart failureRyuichi Ushijima, Shuji Joho, Takashi Akabane, et al.
Journal of Cardiac Failure|June 12, 2016
Restrictive Lung Function Is Related to Sympathetic Hyperactivity in Patients With Heart FailureShuji Joho, Ryuichi Ushijima, Takashi Akabane, et al.
Internal Medicine (Tokyo, Japan)|March 20, 2020
A Young Patient Presenting with Atrioventricular Block Diagnosed as Myotonic DystrophyHiroshi Onoda, Teruhiko Imamura, Ryuichi Ushijima, et al.
Biomedicines|March 29, 2023
Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart FailureMasaki Nakagaito, Teruhiko Imamura, Ryuichi Ushijima, et al.
Journal of Clinical Medicine|June 19, 2024
The Impact of the Withdrawal of SGLT2 Inhibitors on Clinical Outcomes in Patients with Heart FailureMasaki Nakagaito, Teruhiko Imamura, Ryuichi Ushijima, et al.
International Heart Journal|June 1, 2022
Responders to Sodium-Glucose Cotransporter 2 Inhibitors in Improving Left Ventricular FunctionMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
Journal of Clinical Medicine|September 9, 2022
Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart FailureMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
International Heart Journal|July 19, 2021
Relationship Between HbA1c Level and Effectiveness of SGLT2 Inhibitors in Decompensated Heart Failure Patients with Type 2 Diabetes MellitusMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
International Heart Journal|July 19, 2021
Efficacy of Continuing SGLT2 Inhibitors on Outcomes in Patients with Acute Decompensated Heart FailureMasaki Nakagaito, Teruhiko Imamura, Shuji Joho, et al.
Pageof 8